FDA approves Abbvie's treatment to control menstrual bleeding

by Reuters
Friday, 29 May 2020 16:17 GMT

May 29 (Reuters) - The U.S. Food and Drug Administration on Friday approved Abbvie Inc's oral treatment for managing heavy menstrual bleeding associated with fibroids in premenopausal women.

Fibroids are benign muscle tumors of the uterus that can cause heavy menstrual bleeding, pain, bowel or bladder problems and infertility. (Reporting By Mrinalika Roy in Bengaluru; Editing by Shailesh Kuber)

Our Standards: The Thomson Reuters Trust Principles.